parecoxib has been researched along with niflumic acid in 1 studies
| Studies (parecoxib) | Trials (parecoxib) | Recent Studies (post-2010) (parecoxib) | Studies (niflumic acid) | Trials (niflumic acid) | Recent Studies (post-2010) (niflumic acid) |
|---|---|---|---|---|---|
| 436 | 186 | 229 | 720 | 31 | 160 |
| Protein | Taxonomy | parecoxib (IC50) | niflumic acid (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1.064 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.918 | |
| Transcriptional enhancer factor TEF-3 | Homo sapiens (human) | 5.9 | |
| G-protein coupled receptor 35 | Homo sapiens (human) | 1.28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jóźwiak, K; Kocki, T; Targowska-Duda, KM; Turski, WA; Wnorowski, A; Zakrocka, I | 1 |
1 other study(ies) available for parecoxib and niflumic acid
| Article | Year |
|---|---|
Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro.
Topics: Animals; Brain; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Humans; Isoxazoles; Kynurenic Acid; Male; Molecular Docking Simulation; Niflumic Acid; Rats, Wistar; Tissue Culture Techniques; Transaminases | 2019 |